Advanced Wound Care USA 2023

Advanced Wound Care Summit

Uniting industry leaders to foster strategic partnerships, drive innovation, and unlock the potential of wound care products and services

DOWNLOAD AGENDA

ADVANCED WOUND CARE SUMMIT

ALOFT BOSTON SEAPORT DISTRICT, BOSTON
12-13 July, 2023

“A perfect conference for everybody interested in this complex topic, a perfect introduction for the novice, an update for the expert and room for exchange, discussions and networking.”

Helene Lecomte, New Product Development Manager, Smith & Nephew

The Advanced Wound Care Summit is wound care’s only industry-led forum

It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies. 

Whether an established wound care company, an emerging startup, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.

To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more. 

HEAR FROM OUR AUDIENCE

WHO ATTENDS

LEARN MORE                LEARN MORE            LEARN MORE            LEARN MORE

INNOVATION SHOWCASE

If you are an innovative wound care start-up, the Innovation Showcase is a unique opportunity to present your products to our renowned selection committee and the entire live audience – consisting of investors, strategic M&A scouts, CXOs, VPs and Directors of R&D.

Nine companies, hand-picked by our committee, will take to the stand to deliver quick fire presentations about their product or service and how they are aiming to revolutionize wound care.

All applications are stage agnostic and can relate to any solutions within advanced wound care, from anti-biofilm dressings to remote monitoring devices. Apply here to ensure you elevate your brand in a room of potential investors and world leaders of wound care research. Deadline for submissions is June 9th.

The Winner of the showcase will be published in Wound Central and automatically shortlisted into the JWC Awards.

Wound Central brings together the publishing expertise of Journal of Wound Care and over 50,000 health professionals trained by or associated with the WCEI, AAWC AVLS, APWH, and ACCWS, providing a new double-blind peer reviewed journal. Wound Central is targeted at physicians, nurses, scientists, researchers, and academics by bringing together research, reviews and expert opinion pieces all in one place

*All applicants must be interested in attending the event and must purchase a ticket to be a part of the showcase if successful. 

DOWNLOAD INFO PACK   APPLY NOW

INNOVATION SHOWCASE SELECTION COMMITTEE

Author:

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Author:

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Author:

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Author:

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners

Author:

Artem Trotsyuk

Principal
R42 Group

Artem Trotsyuk

Principal
R42 Group

CEO & Founders Forum

The perfect environment for you to establish a credible, peer-to-peer network of wound care entrepreneurs. As the name suggests, this is an exclusive meeting space available to CEOs and Founders only. Join this forum to form relationships with other with like-minded peers and explore the plethora of partnership opportunities available to wound care decision makers.

This forum is limited to only 25 spaces. When securing your place for the event, make sure to register your interest in the forum to avoid missing out on opportunity to network face-to-face with leaders of this thriving community.

WHO YOU WILL MEET

10%
Medical Textiles
35%
Multinational Wound Care Companies
15%
Healthcare Professionals + Academics
30%
Start-ups
10%
CMOs/CDMOs

Medical Textiles

Multinational Wound Care Companies

Healthcare Professionals + Academics

Start-ups

CMOs/CDMOs

2023 SPEAKERS

 

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M

Kris Kieswetter

Global Senior Director, Applied Medical Sciences
3M
 

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem Badejo

Senior R&D Director, External Front End Innovation
Johnson & Johnson

Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.

From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.

Ib received his BA degree in chemistry from Avila University.  He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

 

Jon Bloom

Chief Executive Officer
Podimetrics

Jon Bloom

Chief Executive Officer
Podimetrics

Jon Bloom

Chief Executive Officer
Podimetrics
 

Jignesh Patel

Head of Biologics & Regenerative Medicine
Smith & Nephew

Jignesh Patel

Head of Biologics & Regenerative Medicine
Smith & Nephew

Jignesh Patel

Head of Biologics & Regenerative Medicine
Smith & Nephew
 

Julie Morabito

Assistant Director
FDA

Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

Julie Morabito

Assistant Director
FDA

Julie Morabito

Assistant Director
FDA

Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

 

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight

Monique Rennie

Vice President, Medical Affairs and Reimbursement
MolecuLight
 

Ira Herman

Senior Director, Biological Sciences
Precision Healing

Ira Herman

Senior Director, Biological Sciences
Precision Healing

Ira Herman

Senior Director, Biological Sciences
Precision Healing
 

Katherine Piette

Chief Executive Officer
Corstrata

Katherine Piette

Chief Executive Officer
Corstrata

Katherine Piette

Chief Executive Officer
Corstrata
 

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy

Mike Griffiths

Chief Executive Officer & Medical Director
Advanced Oxygen Therapy
 

Mitch Sanders

CSO
Alira Health

Mitch Sanders

CSO
Alira Health

Mitch Sanders

CSO
Alira Health
 

Davide Vigano

Co-founder and CEO
Sensoria Health

Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line.

Davide Vigano

Co-founder and CEO
Sensoria Health

Davide Vigano

Co-founder and CEO
Sensoria Health

Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide also managed the Italian Marketing, Business and Enterprise operations for five years and brought it to number one in the world for contribution margin, 6th largest Microsoft subsidiary in the world by revenues.

 

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners

Parth Desai

Principal
Flare Capital Partners
 

Chris Rao

SVP Clinical Operations
Alira Health

Chris Rao

SVP Clinical Operations
Alira Health

Chris Rao

SVP Clinical Operations
Alira Health
 

Thomas Serena

Founder & CEO
SerenaGroup

Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

Thomas Serena

Founder & CEO
SerenaGroup

Thomas Serena

Founder & CEO
SerenaGroup

Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.

To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.

He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.

Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

 

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr.

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Nikolai Sopko

Chief Scientific Officer and VP of R&D
PolarityTE, Inc.

Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr. Sopko is currently the Chief Scientific Officer and Vice President of Research and Development of PolarityTE where he applies his passion for patient care and basic science 

 

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny Carberry

Vice President of Business Development
Alira Health

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

 

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance

David Alper

Board Adviser
American Diabetes Association Amputation Prevention Alliance
 

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH

Jens Kirsch

Chief Executive Officer
Terraplasma Medical GMBH
 

Windy Cole

Global Medical Affairs Director
Natrox

Windy Cole

Global Medical Affairs Director
Natrox

Windy Cole

Global Medical Affairs Director
Natrox
 

David Navazio

President & CEO
Gentell Inc.

David Navazio

President & CEO
Gentell Inc.

David Navazio

President & CEO
Gentell Inc.
 

Anthony Kerr

Managing Director
Journal of Wound Care

Anthony Kerr

Managing Director
Journal of Wound Care

Anthony Kerr

Managing Director
Journal of Wound Care
 

Tim Ganey

Chief Scientific Officer
VIVEX Biologics

Tim Ganey

Chief Scientific Officer
VIVEX Biologics

Tim Ganey

Chief Scientific Officer
VIVEX Biologics
 

Dan King

Director of Marketing
Polynovo

Dan King

Director of Marketing
Polynovo

Dan King

Director of Marketing
Polynovo
 

Melissa Bailey

VP of Sales & Marketing
Swift Medical

Melissa Bailey

VP of Sales & Marketing
Swift Medical

Melissa Bailey

VP of Sales & Marketing
Swift Medical
 

Alan Sage

Chief Executive Officer
Vaparox

Alan Sage

Chief Executive Officer
Vaparox

Alan Sage

Chief Executive Officer
Vaparox

CONFERENCE PACKAGE

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket price will increase after

— June 15, 2023 —

Saturday, May 13, 2023 to Friday, June 16, 2023
Early Bird - Save $200
$1,199
EMERGING
Startups (Defined as companies with less than 50 employees, and/or companies that have been operating for less than five years. They must also be actively developing a product for wound care patients.) 
HCPs
Academics
Saturday, May 13, 2023 to Friday, June 16, 2023
Early Bird Ends - Save $200
$1,699
ESTABLISHED
Multinational wound care manufactures
Middle market / Medium-sized enterprises
Big pharma / large med-device companies
Investors
Saturday, May 13, 2023 to Friday, June 16, 2023
Early Bird Ends - Save $300
$3,999
SERVICE PROVIDERS (Defined as companies offering services to med device, medtech and pharmaceutical companies)
Material suppliers
CMOs
CROs
Preparing registration...

ACCESS YOUR COPY OF THE BROCHURE

The 2023 agenda is here!

Fill out the short form to access a copy immediately. 

WHAT’S NEW THIS YEAR?

  1. Interactive Roundtables
    Foster new connections across roundtable discussions centered on the key challenges affecting wound care executives today
  2. Expanded Innovation Showcase
    With opportunities for emerging start-ups and mid-size brands, apply to pitch your innovation to our room of investors and strategic partners
  3. More Key Players
    Meet the game changers from across the industry including 3M, Smith & Nephew, Convatec, Molnlycke and Coloplast, with all stakeholders under one roof
  4. Improved Networking Opportunities
    Meet your next collaborator, with a revamped programme allowing for more business partnering opportunities than ever with over 8 hours of dedicated networking time

FILL OUT YOUR DETAILS BELOW:

DIAMOND PARTNER

GOLD PARTNER

SILVER PARTNER

NETWORKING PARTNER

EXHIBITOR

MEDIA PARTNERS

Partner with us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

RESOURCES

Download Resource

Venue

Aloft Boston Seaport District, 401-403 D Street, Boston, MA, 02210

We're excited to welcome you in Boston at The Aloft Boston Seaport District for the Advanced Wound Care Summit!

To book your room at a discounted rate, please use the link here. This will expire June 23rd.

You can also use Hotel Map: https://hotelmap.com/MYTPK 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us